State Street Corp Seelos Therapeutics, Inc. Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.16 - $1.64 $12,640 - $129,559	79,000 Added 25.13%	393,405 $70,000
Q2 2022 Aug 15, 2022	SELL	$0.51 - $0.93 $729,740 - $1.33 Million	-1,430,864 Reduced 81.99%	314,405 $214,000
Q1 2022 May 16, 2022	BUY	$0.84 - $1.71 $71,370 - $145,290	84,965 Added 5.12%	1,745,269 $1.46 Million
Q4 2021 Feb 14, 2022	BUY	$1.59 - $2.38 $127,901 - $191,449	80,441 Added 5.09%	1,660,304 $2.71 Million
Q3 2021 Nov 15, 2021	BUY	$1.69 - $2.89 $679,543 - $1.16 Million	402,097 Added 34.14%	1,579,863 $3.81 Million
Q2 2021 Aug 16, 2021	BUY	$2.64 - $6.32 $3.11 Million - $7.44 Million	1,177,766 New	1,177,766 $3.11 Million

40.5K

Ticker SEEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 106,691,000
Market Cap $312M
Description
Seelos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of central nervous system, respiratory, and other disorders. The company's lead programs are SLS-002, an intranasal racemic ketamine for the treatment of acute suicidal ideation and behavior in...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.